GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Repurchase of Stock

RNUGF (ReNeuron Group) Repurchase of Stock : $0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group Repurchase of Stock?

ReNeuron Group's Repurchase of Stock for the six months ended in Sep. 2023 was $0.00 Mil.

ReNeuron Group's Repurchase of Stock for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.


ReNeuron Group Repurchase of Stock Historical Data

The historical data trend for ReNeuron Group's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Repurchase of Stock Chart

ReNeuron Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Repurchase of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ReNeuron Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Repurchase of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ReNeuron Group Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ReNeuron Group Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


ReNeuron Group Business Description

Traded in Other Exchanges
N/A
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.

ReNeuron Group Headlines

From GuruFocus

Full Year 2019 ReNeuron Group PLC Earnings Call Transcript

By GuruFocus Research 02-14-2024

ReNeuron Update Regarding COVID-19

By PRNewswire PRNewswire 04-07-2020

ReNeuron Signs New Exosome Research Collaboration

By PRNewswire PRNewswire 06-25-2020

Edison Issues Outlook on ReNeuron Group (RENE)

By ACCESSWIRE ACCESSWIRE 08-26-2020

Edison Issues Update on ReNeuron Group (RENE)

By ACCESSWIRE ACCESSWIRE 07-06-2020

ReNeuron Expands Exosome IP Portfolio with Key Patent Grants

By PRNewswire PRNewswire 07-16-2019

ReNeuron Provides Program and Regulatory Approvals Update

By PRNewswire PRNewswire 06-17-2020

Full Year 2022 ReNeuron Group PLC Earnings Call Transcript

By GuruFocus Research 02-14-2024